Barclays on Eli Lilly (LLY): Centessa a 'sensible tuck-in' for neuroscience division
Tweet Send to a Friend
Barclays analyst Emily Field reiterated an Overweight rating and $1,350.00 price target on Eli Lilly (NYSE: LLY)The analyst commented ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
